Mu-Opioid Receptors: Definition and Function
Mu-opioid receptors (MORs) are inhibitory G protein-coupled receptors distributed throughout the brain, spinal cord, and peripheral tissues that mediate the primary analgesic effects of opioid medications as well as their euphoric, addictive, and life-threatening respiratory depressant properties. 1
Receptor Classification and Distribution
There are four types of opioid receptors (mu, kappa, delta, and nociceptin), but every opioid agonist causes most of its effects by binding to the mu receptor. 1
MORs are highly concentrated in brain regions that regulate pain perception including the periaqueductal gray, thalamus, cingulate cortex, and insula, which explains their effectiveness for severe acute pain management. 2
MORs are also densely expressed in reward circuitry (ventral tegmental area, nucleus accumbens), accounting for opioids' pleasurable effects and addiction potential. 2
Critical MOR expression in the brainstem respiratory center (pre-Bötzinger complex) explains why opioids can depress respiration and cause overdose deaths. 2
Mechanism of Action
Agonist binding to mu opioid receptors produces strong analgesia through brain mechanisms and intermediate analgesia via spinal mechanisms. 1
MOR activation triggers a cascade of intracellular activity that increases dopamine release in the brain's reward circuitry, mediating euphoria and reinforcing properties. 3
The receptor functions by reducing intracellular cAMP concentration through inhibition of adenylyl cyclase activity and by inhibiting neuronal firing through modulation of membrane ion channels. 4
Gastrointestinal Effects
Opioid-induced constipation occurs primarily via activation of enteric mu-receptors located in the small intestine and proximal colon (kappa-receptors also contribute in the stomach and small intestine). 5
MOR activation results in increased tonic non-propulsive contractions in the small and large intestine, increased colonic fluid absorption, stool desiccation, increased minimum sensory threshold of the rectum, and increased anal sphincter tone. 5
Additional Organ System Effects
Beyond analgesia and gastrointestinal effects, MOR activation produces: 1
- Cardiovascular effects: Bradycardia from parasympathetic activity and orthostatic hypotension at very high doses
- Respiratory effects: Dose-dependent ventilatory depression and decreased responsiveness to carbon dioxide
- Nervous system effects: Euphoria, miosis, nausea via chemoreceptor trigger zone activation, and pruritus via medullary receptor activation
- Biliary effects: Sphincter of Oddi spasm and increased intrabiliary pressure
- Genitourinary effects: Increased urinary bladder sphincter tone
Receptor Heterogeneity and Complexity
A single gene encodes mu opioid receptors, but this gene undergoes extensive splicing to generate multiple protein variants (splice variants), which may explain clinical variability in patient responses to different opioid medications. 6
MOR can form heterodimers with other opioid receptors (delta, kappa) and non-opioid receptors both in vitro and in vivo, creating distinct pharmacological properties, different binding affinities for ligands, altered downstream signaling, and modified receptor trafficking. 7
Evidence suggests that MOR heterodimers represent potential novel therapeutic targets for developing safer analgesics with reduced side effects. 7
Clinical Relevance
The differential distribution of MORs across pain-processing, reward, and respiratory centers creates the fundamental therapeutic challenge: effective analgesia cannot be separated from addiction risk and respiratory depression using current non-selective mu agonists. 2
Opioid medications vary in their binding affinity and selectivity for mu, kappa, and delta receptors, which determines their relative potency, and they differ in pharmacokinetics and bioavailability, which determines rapidity and duration of action. 2